Monoclonal plasma cell infiltration of eczematous skin in a patient with multiple myeloma
Related Experiment Videos
Archives of Dermatological Research
|January 1, 1980
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Malignant atrophic papulosis (Köhlmeier-Degos disease). Failure to respond to interferon alpha-2a, pentoxifylline and aspirin].
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2002
[Erysipelas carcinomatosum in tubular adenocarcinoma of the stomach].
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2001
Type 2 segmental manifestation of Hailey-Hailey disease: poor therapeutic response to dermabrasion is due to severe involvement of adnexal structures.
European journal of dermatology : EJD·2000
[Cutaneous sinus histiocytosis (Rosai-Dorfman disease)].
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·1998
[Delayed type allergic reaction to red azo dye in tattooing].
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·1997
Transgender Individuals' Perspectives on Teledermatology-Based Acne Research.
Archives of dermatological research·2026
Nicotinamide for secondary keratinocyte carcinoma prevention in solid organ transplant recipients.
Archives of dermatological research·2025
Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review.
Archives of dermatological research·2025
Wells syndrome: emerging triggers and treatments- an updated systematic review.
Archives of dermatological research·2025
Comparative study between intralesional acyclovir versus intralesional 5-flurouracil in treatment of recalcitrant warts.
Archives of dermatological research·2025
Recurrent Reactions to Enzyme Replacement Therapy in Infantile-Onset Pompe Disease: A Case of Immunologic Barriers to Drug Tolerance.
American journal of medical genetics. Part A·2026
52-Week Safety and Disease Control With Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From the Phase 3 TRuE-AD3 Study.
Journal of the American Academy of Dermatology·2026